Profil
Sanjeev Pandya served as Senior Independent Non-Executive Director at ImmuPharma Plc from 2021 to 2023.
Prior to that, he was ED & EVP-Global Business Development at Advanced Oncotherapy Plc from 2016 to 2018.
He also worked at Reckitt Benckiser Group Plc as Head-Europe Regulatory & Medical.
Dr. Pandya holds an MBA from INSEAD and a doctorate from Trinity College, Cambridge.
Anciens postes connus de Sanjeev Pandya
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUPHARMA PLC | Directeur/Membre du Conseil | 11/08/2023 |
| ADVANCED ONCOTHERAPY PLC | Directeur Général | 08/02/2016 |
| RECKITT BENCKISER GROUP PLC | Corporate Officer/Principal | - |
Formation de Sanjeev Pandya
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Advanced Oncotherapy Plc
Advanced Oncotherapy Plc Medical SpecialtiesHealth Technology Develops and provides advanced cancer treatments | Health Technology |
Reckitt Benckiser Group Plc
Reckitt Benckiser Group Plc Household/Personal CareConsumer Non-Durables Manufactures and markets household cleaning, health and nutrition products | Consumer Non-Durables |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmuPharma Plc
ImmuPharma Plc Pharmaceuticals: OtherHealth Technology Discovers and develops pharmaceutical drugs | Health Technology |
Trinity College, Cambridge
Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















